Canada - English - Health Canada

janssen inc - esketamine (esketamine hydrochloride) - solution - 28mg - esketamine (esketamine hydrochloride) 28mg - miscellaneous antidepressants

Israel - English - Ministry of Health

j-c health care ltd - esketamine as hydrochloride - solution for spray - esketamine as hydrochloride 28 mg/vial - esketamine - spravato, in combination with a ssri or snri, is indicated for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.spravato, co-administered with oral antidepressant therapy, is indicated in adults with a moderate to severe episode of major depressive disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.limitations of use: the effectiveness of spravato in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. use of spravato does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of spravato.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - esketamine hcl 32.2mg eqv. to esketamine - spray - esketamine hcl 32.2mg eqv. to esketamine 28mg/vial

European Union - English - EMA (European Medicines Agency)

janssen-cilag international nv - esketamine hydrochloride - depressive disorder - other antidepressants - spravato, in combination with a ssri or snri, is indicated for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - esketamine 28 mg/200mcl - 28 mg/200mcl

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - esketamine hcl 28 mg/200mcl - 28 mg/200mcl

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - esketamine hcl 28 mg/200mcl - 28 mg/200mcl

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - esketamine hydrochloride 161.4 mg/ml equivalent to esketamine 140 mg/ml;   - nasal spray solution - 140 mg/ml - active: esketamine hydrochloride 161.4 mg/ml equivalent to esketamine 140 mg/ml   excipient: citric acid monohydrate edetic acid sodium hydroxide water for injection - spravato in conjunction with an oral antidepressant, is indicated for: - treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current depressive episode). - rapid reduction of depressive symptoms in patients with major depressive disorder who have acute suicidal ideation or behaviour. spravato is not indicated to prevent suicide or in reducing suicidal ideation or behaviour